Skip to Main Content

Latest News

Understanding Poor Vaccine Responses in Individuals With Weakened Immune Systems

Yale researchers have received a $12 million award from the NIH as part of the Human Immune Project Consortium to study vaccine responses in vulnerable groups, including patients with multiple sclerosis (MS) undergoing B cell depletion therapy, older adults including particularly vulnerable older residents of long-term care facilities, and certain individuals with sickle cell disease.

Read more